Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/11/2018
SIETES contiene 92588 citas

 
 
 1 a 20 de 198 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Diallo T, Adjobimey M, Ruslami R, Trajman A, Sow O, Baah JO, Marks GB, Long R, Elwood K, Zielinski D, Gninafon M, Wulandari DA, Apriani L, Valiquette C, Fregonese F, Hornby K, Li P-Z, Hill PC, Schwartzman K, Benedetti A, Menzies D. Safety and side effects of rifampin versus isoniazid in children. N Engl J Med 2018;379:2 de agosto. [Ref.ID 102756]
2.Tiene citas relacionadas Cita con resumen
Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Baah JO, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata KE, Kritski A, Rolla V, Bah B, Camara A, Boakye I, Cook VJ, Goldberg H, Valiquette C, Hornby K, Dion-M-J, Li P-Z, Schwartzman K, Benedetti A. Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N Engl J Med 2018;379:2 de agosto. [Ref.ID 102755]
3. Cita con resumen
Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Chir B, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD, for the Thibela TB Study Team. A trial of mass isoniazid preventive therapy for tuberculosis control . N Engl J Med 2014;370:301-10. [Ref.ID 97030]
4. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
5.
Vodovar D, LeBeller C, Mégarbane B, Lillo-Le-Louet A, Hanslik T. Drug fever: a descriptive cohort study from the French National Pharmacovigilance Database. Drug Saf 2012;35:759-67. [Ref.ID 93643]
6. Cita con resumen
Kmietowicz Z. New drug combination for TB is tested in unique trial. BMJ 2012;345:4-5. [Ref.ID 93500]
7. Cita con resumen
Anónimo. Constipations d'origine médicamenteuse chez les adultes. Prescrire 2012;32:430-5. [Ref.ID 93122]
8. Cita con resumen
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bilven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh Jr CR, Chaisson RE, for the TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155-66. [Ref.ID 91928]
9.Tiene citas relacionadas
Nardell E, Churchyard G. What is thwarting tuberculosis prevention in high-burden settings?. N Engl J Med 2011;365:79-81. [Ref.ID 90907]
10.Tiene citas relacionadas
Madhi SA, Nachman S, Violari A, Kim S, Cotton MF, Bobat R, Jean-Philippe P, McSherry G, Mitchell C, for the P1041 Study Team. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011;365:21-31. [Ref.ID 90904]
11.Tiene citas relacionadas
Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011;365:11-20. [Ref.ID 90903]
12.Tiene citas relacionadas
Samandari T, Agizeuw TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat HJ, Kilmarx PH, Castro KG, Wells CD. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011;377:1588-98. [Ref.ID 90806]
13.Tiene citas relacionadas
Dodd LE, Wilkinson RJ. Isoniazid preventive therapy in HIV infection. Lancet 2011;377:1548-50. [Ref.ID 90803]
14. Cita con resumen
Chang C, Gershwin ME. Drug-induced lupus erythematosus. Incidence, management and prevention. Drug Saf 2011;34:357-74. [Ref.ID 90404]
15. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
16. Cita con resumen
Hughes R. Investigation of peripheral neuropathy. BMJ 2010;341:1161-2. [Ref.ID 89724]
17.Tiene citas relacionadas Cita con resumen
Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ 2010;341:596. [Ref.ID 89389]
18.Tiene citas relacionadas
Blomberg B, Langeland N. Tuberculous meningitis and resistance to isoniazid. BMJ 2010;341:565-6. [Ref.ID 89380]
19. Cita con resumen
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010;33:713-26. [Ref.ID 89267]
20.Tiene citas relacionadas
Chaisson RE, Chaudhary MA, Conde MB. Moxifloxacin versus ethambutol in initial tuberculosis treatment. Authors' reply. Lancet 2009;373:2198-9. [Ref.ID 86129]
Seleccionar todas
 
 1 a 20 de 198 siguiente >>